dr. gradishar discusses dual her2-targeting in breast cancer
Published 7 years ago • 77 plays • Length 0:50Download video MP4
Download video MP3
Similar videos
-
2:21
dr. gradishar discusses advances in the treatment of her2-positive breast cancer
-
1:44
dr. gradishar discusses the treatment of her2 breast cancer
-
2:06
dr. gradishar on personalized treatment in breast cancer
-
0:41
dr. freedman discusses dual her2-targeted therapy in breast cancer
-
55:48
new & supporting data for optimizing therapy in her2 breast cancer | dr. bagegni & dr. gradishar
-
2:04
dr. gradishar on using genetic testing to identify actionable results in breast cancer
-
0:52
dr. gradishar on the role of neratinib in the treatment of her2 breast cancer
-
2:57
dr. gradishar comments on the treatment of early stage breast cancer with endocrine therapy
-
3:45
evolving landscape of her2-targeted therapy in breast cancer
-
7:41
her2-targeted therapy in early stage her2 breast cancer
-
1:49
dr. murthy on dual her2 blockade in her2 breast cancer
-
8:39
breast cancer: dual her2-targeted adjuvant therapy
-
7:44
hormonal and her2-targeted therapy in early breast cancer
-
1:06
dr. tripathy on determining the best her2 targeted therapy
-
1:18
dr. hamilton discusses the katherine trial in her2 breast cancer
-
1:39
dr. hurvitz on the lack of predictive biomarkers in her2 breast cancer
-
4:45
evolving role of her2-targeted therapy in breast cancer
-
0:57
dr. marks on the role of tkis in her2-positive breast cancer
-
2:36
dr. blackwell discusses tucatinib in her2 breast cancer